116351 ⎘
Hydrolases acting on ester bonds (3.1); Phosphoric monoester hydrolases (3.1.3) Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase (3.1.3.67)
MOLECULAR THERAPEUTIC STRATEGY COMBINING IDELALISIB AND SRPIN340 TO TREAT ADVANCE SOLID TUMORS
#2Compositions and Methods of Generating Novel amiRNA
#3EXPRESSION OF PTEN-LONG WITH ONCOLYTIC VIRUSES
#4Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
#5Oncolytic virus for treating brain tumors using recombinant Newcastle disease virus into which Newcastle disease virus vector-based PTEN gene is inserted and composition for treating brain tumors using same
#6Neoantigen peptide mimics
#7TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS
#8MODIFIED MITOCHONDRIA AND USE THEREOF
#9Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#10PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MRNA
#11TREATMENT OF DAMAGED NERVE WITH PTEN INHIBITOR
#12Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF
#13EXPRESSION OF PTEN-LONG WITH OCOLYTIC VIRUSES
#14Treatment of CNS injury with RNAi therapeutics
#15Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
#16Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#17Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
#18Treatment of damaged nerve with PTEN inhibitor
#19Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#20Vault and vault like carrier molecules
#21Pharmaceutical angiogenic composition including a microRNA-382 activator
#22Vault and vault-like carrier molecules
#23Vault and vault-like carrier molecules